Search results
Benjamin F. Edwards & Company Inc. Acquires 1,987 Shares of Boston Scientific Co. (NYSE:BSX)
ETF DAILY NEWS· 5 days agoBenjamin F. Edwards & Company Inc. lifted its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 17.5% during the fourth quarter, according to ...
Boston Scientific Elects Dr. Cheryl Pegus to Board of Directors
Morningstar· 4 days agoMARLBOROUGH, Mass., May 8, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today the election of Dr. Cheryl Pegus to its board ...
The Zacks Analyst Blog Highlights Alphabet, Netflix, Amazon, ServiceNow and Boston Scientific
Zacks via Yahoo Finance· 6 days agoGOOGL, Netflix Inc. NFLX, Amazon.com Inc. AMZN, ServiceNow Inc. NOW and Boston Scientific Corp. BSX....
Inogen (INGN) Q1 Earnings Top Estimates, Revenues Up Y/Y
Zacks· 4 days agoFree Report) incurred an adjusted loss per share of 45 cents for first-quarter 2024, which was...
Inspire Medical Q1 Earnings Beat, Gross Margin Up - Boston Scientific (NYSE:BSX), Align Tech...
Benzinga· 3 days agoInspire Medical Systems, Inc. INSP delivered a loss per share of 34 cents in first-quarter 2024,...
Catalent (CTLT) Q3 Earnings Lag Estimates, Gross Margin Up
Zacks· 4 days agoCatalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y
Zacks via Yahoo Finance· 3 days agoSome better-ranked stocks in the broader medical space that have announced quarterly results are...
QuidelOrtho (QDEL) Q1 Earnings Beat Estimates, Margins Fall
Zacks via Yahoo Finance· 3 days agoSome better-ranked stocks in the broader medical space that have announced quarterly results are...
AMN Healthcare (AMN) Q1 Earnings and Revenues Beat Estimates
Zacks via Yahoo Finance· 2 days agoSome better-ranked stocks in the broader medical space that have announced quarterly results are...
Neogen (NEOG) Faces Macroeconomic Issues, Fierce Competition
Zacks· 3 days agoNeogen's (NEOG Quick QuoteNEOG - Free Report) vast international trade continues to be impacted by global macroeconomic issues. Neogen currently carries a Zacks Rank #4 (Sell). Neogen’s business ...